GANMAOLING
- Product NDC
- 72030-002
- 11-digit product format
- 720300002
- Labeler code
- 72030
- Product ID
- 72030-002_43e72532-332c-65b7-e063-6294a90aca7a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-11-26
- Marketing end
- 2029-08-30
- Substance
- ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE
- Active strength
- 60; .667 mg/1; mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 72030-002-01 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 72030-002-01 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 72030-002-01 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 72030-002-01 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 72030-002-01 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 72030-002-01 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 72030-002-01 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 72030-002-01 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GANMAOLING
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 60 mg/1 |
| CHLORPHENIRAMINE MALEATE | .667 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| V1Q0O9OJ9Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1599133 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c757a03e-59ea-469c-970d-4bc62e73f36f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d17a97fa-387f-690e-d2be-0083ab044a03 | Product name | 3 | 20170725 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| c6fba691-a132-4ede-95c6-f8c6bd696636 | Product name | 1 | 20150902 |
| c0200ab5-4954-454e-9676-30b741b245bd | Product name | 1 | 20150730 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72030-002-01 | 2025-11-18 | C162847 | 48780-1 | 2cef2736-70f4-d83d-e063-dadaa90ab31f | DRUG FACTS |
| 72030-002-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-70f4-d83d-e063-dadaa90ab31f | DRUG FACTS |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72030-002-01 | GANMAOLING | 1 in 1 BOX | TABLET | 1 | 2 | |
| 72030-002-01 | GANMAOLING | 120 in 1 BOTTLE | TABLET | 120 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72030-002 | GANMAOLING (ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE) TABLET [ANHUI DONGSHENGYOUBANG PHARMACEUTICAL CO., LTD.] | 1 | Current NDC, Legacy NDC, 2 package rows | 20181130_c757a03e-59ea-469c-970d-4bc62e73f36f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Afrin Original Pump Mist | OXYMETAZOLINE HYDROCHLORIDE | Bayer HealthCare LLC. | 0f5ec576-f788-40aa-9088-0dd672e3cc7c | 2025-12-04 | Warnings | M012 |
| Adult Long Lasting Cough Relief | DEXTROMETHORPHAN HBR | Shield Pharmaceuticals Corp | 432a79a9-c69d-4514-894a-7832e1b745ef | 2025-12-04 | Warnings | M012 |
| GENCONTUSS | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | KRAMER NOVIS | 69d16d25-b09b-430e-8e01-0962d840dc21 | 2025-12-04 | Warnings | M012 |
| Nasal Decongestant PE | PHENYLEPHRINE HCL | H E B | 7c04ab14-af28-4598-90ef-56ac11902c7d | 2025-12-04 | Warnings | M012 |
| Desgen Pediatric | DEXTROMETHORPHAN HBR, GUIAFENESIN, PHENYLEPHRINE HCL | Kramer Novis | 12425c1b-8bdc-446b-83dd-95e05a4d9b8c | 2025-12-04 | Warnings | M012 |
| Presgen B | DEXTROMETHORPHAN HYDROBROMIDE, BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | KRAMER NOVIS | 5befa829-32bd-4978-8a0e-1d6513ff37a4 | 2025-12-03 | Warnings | M012 |
| TUSSLIN | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Kramer Novis | 987e19a5-032f-44e9-b4c7-8a764d502695 | 2025-12-03 | Warnings | M012 |
| DayTime Relief, Cold and Flu, 24-7 Life by 7-Eleven | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL SOLUTION | Lil' Drug Store Products, Inc. | 450e8974-8ff8-4b82-e063-6394a90a9366 | 2025-12-03 | Warnings | M012 |
| Nighttime Relief, Cold and Flu, 24-7 Life by 7-Eleven | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE SOLUTION | Lil' Drug Store Products, Inc. | 4510223f-1c88-2796-e063-6394a90a18ac | 2025-12-03 | Warnings | M012 |
| Carolina Crud Crusher | DEXTROMETHORPHAN HBR, GUAIFENESIN | Weeks & Leo Co., Inc. | 0b606683-7d68-cca5-e063-6394a90a6f58 | 2025-12-03 | Warnings | M012 |
| Capmist DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Capital Pharmaceutical, LLC | 63733ac3-859e-4a8e-8717-d852bd303408 | 2025-12-03 | Warnings | M012 |
| ALA-HIST IR | DEXBROMPHENIRAMINE MALEATE | Poly Pharmaceuticals, Inc. | 0d203b5c-8b10-428b-8703-17be6b4ce6eb | 2025-12-03 | Warnings | M012 |
| ALAHIST DM | DEXTROMETHORPHAN HBR, PHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Poly Pharmaceuticals, Inc. | fdaa062d-110e-798d-e053-6394a90a755c | 2025-12-03 | Warnings | M012 |
| Alahist D | PHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Poly Pharmaceuticals, Inc. | a1b8533a-ef8b-57cc-e053-2995a90a5d9e | 2025-12-03 | Warnings | M012 |
| Alahist PE | DEXBROMPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | Poly Pharmaceuticals, Inc. | ada2d582-5813-2029-e053-2a95a90ae567 | 2025-12-03 | Warnings | M012 |
| Benadryl Allergy Extra Strength Liqui-Gels | DIPHENHYDRAMINE HYDROCHLORIDE | Kenvue Brands LLC | 30aca3ab-b091-3939-e063-6294a90a9819 | 2025-12-03 | Warnings | M012 |
| Cough and Cold HBP | CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR | L.N.K. International, Inc. | 9f2daffc-1904-4d64-9f84-689c88601e06 | 2025-12-03 | Warnings | M012 |
| Childrens Multi-symptom Cold | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Wal-Mart Stores, Inc. | d291faa9-894e-421c-8115-8a8c2a937172 | 2025-12-03 | Warnings | M012 |
| SINUS PAIN AND CONGESTION | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | CVS Pharmacy | 697dffdd-5b56-4395-8e69-6b4360d9fdc5 | 2025-12-02 | Warnings | M012 |
| Maximum Strength Mucus Relief Severe Congestion and Cough | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Wal-Mart Stores,Inc., | 9c8c1974-f931-4493-abb5-ecdc32764ab3 | 2025-12-02 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1599133 | acetaminophen 60 MG / chlorpheniramine maleate 0.667 MG Oral Tablet | PSN | c757a03e-59ea-469c-970d-4bc62e73f36f | 2 |
| 1599133 | acetaminophen 60 MG / chlorpheniramine maleate 0.667 MG Oral Tablet | SCD | c757a03e-59ea-469c-970d-4bc62e73f36f | 2 |
| 1599133 | APAP 60 MG / Chlorpheniramine Maleate 0.667 MG Oral Tablet | SY | c757a03e-59ea-469c-970d-4bc62e73f36f | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72030-002-01 | 72030000201 | 1 BOTTLE in 1 BOX (72030-002-01) / 120 TABLET in 1 BOTTLE | 1 bottle | 2018-11-26 | 2029-08-30 | No | No | Current |